Comparison of the pharmacokinetics of lidamycin in mice determined by two methods

Yaoxue Xuebao

Volumn 39, Issue 9, 2004, Pages 695-699

  Liu, You Ping ^a,b   Li, Quan Sheng ^a   Huang, Yu Rong ^a   Liu, Chang Xiao ^a  

^a TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

High performance liquid chromatography; Lidamycin; Pharmacokinetics; Radio labeling

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; IODINE 125; LIDAMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL MOUSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; RADIOACTIVITY; SEPARATION TECHNIQUE; STATISTICAL ANALYSIS;

AMINOGLYCOSIDES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENEDIYNES; FEMALE; IODINE RADIOISOTOPES; ISOTOPE LABELING; MALE; MICE; SENSITIVITY AND SPECIFICITY;

EID: 11444261613     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hu JL, Xue YC, Xie MY, et al. A new macromolecular antitumor antibiotic, C-1027, I. Discovery, taxonomy of producing organism, fermentation and biological activity [J]. J Antibiot, 1988,41(11) :1575-1579.
2. Otani T, Minami Y, Marunaka T, et al. A new macromolecular antitumor antibiotic, C-1027. II. Isolation and physico-chemical properties [J]. J Antibiot, 1988,41(11) :1580-1585.
3. Zhen YS, Ming XY, Yu B, et al. A new macromolecular antitumor antibiotic, C-1027. III. Antitumor activity [J]. J Antibiotic, 1989, 42(8) :1294-1298.
4. Otani T, Minami Y, Dakawa K, et al. Isolation and characterzation of non-protein chromophore and its degradation product from antibiotic C-1027 [J]. J Antibiot, 1991,44(5) :564-568.
5. Shao RG, Zhen YS. Relationship between the molecular composition of C-1027, a new macromolecular antibiotic with enediyne chromophore, and its antitumor activity [J]. Acta Pharm Sin, 1995,30(5) :336-342.
6. Xu YJ, Li DD, Zhen YS. Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells [J]. Cancer Chemother Pharmacol, 1990,27(1) :41-46.
7. Tang ZM, Liu XW, Xu LP, et al. Pharmacokinetics and tissue distribution of human recombinant interleukin-2 in mice [J]. Acta Pharm Sin, 1994,29(1) : 51-56.
8. Otani T, Yasuhara T, Minami Y, et al. Purification and primary structure of C-1027-AG, a selective antagonist of antitumor C-1027, from streptomyces globisporus [J]. Agric Biol Chem, 1991,55(2) :407-417.
9. Liu CX, Wei GL, Li QS. Methodology study of validation for bioanalysis in studies on pharmacokinetics and bioavailability [J]. Asian J Drug Metab Pharmacokinet, 2001,1(4) :279-286.
10. Shah VP, Midha KK, Dighe S, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies [J]. Eur J Drug Metab Pharmacokinet, 1991,16(4) :309-312.
11. Liu YP, Zhou MJ. Bioanalytical method for the pharmacokinetic and toxicokinetic studies of biotechnology-derived pharmaceuticals [J]. Asian J Drug Metab Pharmacokinet, 2002,2(3) :209-221.